Group 1 - The core viewpoint of the news is that Steady Medical (300888) has shown significant growth in its financial performance, with a notable increase in revenue and net profit for the first three quarters of 2025 compared to the previous year [2] - As of January 19, 2026, Steady Medical's stock closed at 36.55 yuan, with a slight increase of 0.55% and a trading volume of 61,600 lots, amounting to a total transaction value of 225 million yuan [1] - The company reported a main business revenue of 7.897 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% year-on-year [2] Group 2 - In the third quarter of 2025, the company achieved a single-quarter main business revenue of 2.601 billion yuan, which is a 27.71% increase year-on-year, and a net profit of 240 million yuan, reflecting a 42.11% year-on-year growth [2] - The company has a debt ratio of 33.87% and reported investment income of 33.23 million yuan, with financial expenses of -2.036 million yuan, indicating a strong financial position [2] - The gross profit margin for Steady Medical stands at 48.32%, showcasing its efficiency in managing production costs [2]
股票行情快报:稳健医疗(300888)1月19日主力资金净买入798.81万元